Immune checkpoint inhibitor-related myositis associated with atezolizumab therapy

Immune checkpoint inhibitor-related myositis should be considered in the differential diagnosis of patients presenting with acute weakness even if atezolizumab had been commenced many weeks beforehand.

Source: Neurology Clinical Practice - June 9, 2019 Category: Neurology Authors: Khoo, A., Zhuang, Y., Boundy, K., Frasca, J. Tags: Autoimmune diseases, Muscle disease, Metastatic tumor Case Source Type: research